LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Krispy Kreme, Inc. ("Krispy Kreme" or the "Company") (NASDAQ: DNUT) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE: DV) have opportunity to lead the securities fraud class action lawsuit.

Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES , July 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against MicroStrategy Incorporated d/b/a Strategy ("Strategy" or the "Company") (NASDAQ: MSTR).

LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) have opportunity to lead the securities fraud class action lawsuit.

LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) have opportunity to lead the securities fraud class action lawsuit.

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a global advisory, broking and solutions company, today announced that Alena Kharkavets has been appointed North American Head of Claims in its Insurance Consulting and Technology (ICT) business.

LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) securities between May 2, 2024, to May 6, 2025, inclusive (the “Class Period”).

Transaction in Own Shares 7 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 7 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 07/07/2025 1,121,793 £25.7950 £25.4250 £25.5846 LSE GBP 07/07/2025 155,410 £25.8400 £25.4250 £25.5968 Chi-X (CXE) GBP 07/07/2025 102,797 £25.7650 £25.4350 £25.5619 BATS (BXE) GBP 07/07/2025 938,534 €30.1050 €29.5900 …

V teams up with BNPL firms like Klarna and Afterpay to stay central in payments as credit habits shift.

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like CRS, ATI, GE and LHX offer strong growth potential.

CNBC's Brian Sullivan joins 'Squawk on the Street' to discuss the latest news on the energy market.

NEW YORK--(BUSINESS WIRE)--HSBC's new Affluent Investor Snapshot 2025 reveals that affluent investors doubled their allocations to alternative investments over the past year. The trend looks set to continue, holding strong appeal into the future as investors seek to further diversify their portfolios. Around half of the global affluent investors in the survey of 10,797 individuals in 12 markets say they plan to own alternative investments within the next 12 months, doubling the current ownershi.

Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approval from the Food and Drug Administration (FDA).

Apogee Therapeutics (NASDAQ:APGE) shares fell almost 15% despite the release of positive Phase 2 APEX trial results for APG777, its anti-IL-13 antibody for moderate-to-severe atopic dermatitis. The trial met its primary endpoint with a 71% reduction in Eczema Area Severity Index (EASI) score at Week 16, versus 33.8% for placebo.

HWM soars 65.6% YTD on aerospace and defense strength, but investors must weigh growth prospects against rich valuation.

Azoria CEO James Fishback says Elon Musk should focus his time on Tesla and SpaceX and not trying to sabotage President Donald Trump. Fishback, a shareholder, says if Musk doesn't want to be a fulltime CEO, he "should tell us now.

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

Uncertainty creates value opportunities. In this article, I highlight two value stocks trading far below their historical valuations. Both offer dividend yields that are well above historical average and strong growth potential. Both stocks exemplify how investors can secure decent yields and future upside by buying quality companies when market sentiment is overly pessimistic.

As quantum computing leader D-Wave Quantum Inc. NYSE: QBTS announced the completion of its $400-million at-the-market equity offering, the company's share price spiked by more than 19% in under a week.

Nvidia Corporation's fundamentals remain robust, with new AI-driven growth catalysts emerging across data centers, industrial AI, robotics, and cloud services. Strong partnerships and vertical integration in Europe and beyond are deepening Nvidia's AI ecosystem moat, driving recurring revenues and innovation. NVDA stock valuation remains attractive versus peers and historical averages, supporting a 34%+ upside and reaffirming my Strong Buy rating.